The Generation of an Engineered Interleukin-10 Protein With Improved Stability and Biological Function.
Ontology highlight
ABSTRACT: Interleukin-10 (IL-10) is an immunoregulatory cytokine that plays a pivotal role in modulating inflammation. IL-10 has inhibitory effects on proinflammatory cytokine production and function in vitro and in vivo; as such, IL-10 is viewed as a potential treatment for various inflammatory diseases. However, a significant drawback of using IL-10 in clinical application is the fact that the biologically active form of IL-10 is an unstable homodimer, which has a short half-life and is easily degraded in vivo. Consequently, IL-10 therapy using recombinant native IL-10 has had only limited success in the treatment of human disease. To improve the therapeutic potential of IL-10, we have generated a novel form of IL-10, which consists of two IL-10 monomer subunits linked in a he
SUBMITTER: Minshawi F
PROVIDER: S-EPMC7431522 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
ACCESS DATA